1. Home
  2. CBT vs AXSM Comparison

CBT vs AXSM Comparison

Compare CBT & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBT
  • AXSM
  • Stock Information
  • Founded
  • CBT 2019
  • AXSM 2012
  • Country
  • CBT United States
  • AXSM United States
  • Employees
  • CBT N/A
  • AXSM N/A
  • Industry
  • CBT Major Chemicals
  • AXSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • CBT Industrials
  • AXSM Health Care
  • Exchange
  • CBT Nasdaq
  • AXSM Nasdaq
  • Market Cap
  • CBT 4.9B
  • AXSM 4.2B
  • IPO Year
  • CBT N/A
  • AXSM 2015
  • Fundamental
  • Price
  • CBT $84.48
  • AXSM $137.75
  • Analyst Decision
  • CBT Hold
  • AXSM Strong Buy
  • Analyst Count
  • CBT 4
  • AXSM 14
  • Target Price
  • CBT $97.00
  • AXSM $158.93
  • AVG Volume (30 Days)
  • CBT 465.4K
  • AXSM 1.2M
  • Earning Date
  • CBT 02-03-2025
  • AXSM 02-18-2025
  • Dividend Yield
  • CBT 2.04%
  • AXSM N/A
  • EPS Growth
  • CBT N/A
  • AXSM N/A
  • EPS
  • CBT 7.51
  • AXSM N/A
  • Revenue
  • CBT $3,991,000,000.00
  • AXSM $385,693,000.00
  • Revenue This Year
  • CBT $4.26
  • AXSM $45.18
  • Revenue Next Year
  • CBT $3.75
  • AXSM $65.22
  • P/E Ratio
  • CBT $11.24
  • AXSM N/A
  • Revenue Growth
  • CBT 1.71
  • AXSM 42.53
  • 52 Week Low
  • CBT $82.27
  • AXSM $64.11
  • 52 Week High
  • CBT $117.46
  • AXSM $139.13
  • Technical
  • Relative Strength Index (RSI)
  • CBT 36.42
  • AXSM 74.55
  • Support Level
  • CBT $84.53
  • AXSM $124.04
  • Resistance Level
  • CBT $88.86
  • AXSM $130.52
  • Average True Range (ATR)
  • CBT 2.09
  • AXSM 5.78
  • MACD
  • CBT 0.23
  • AXSM 1.11
  • Stochastic Oscillator
  • CBT 15.83
  • AXSM 96.07

About CBT Cabot Corporation

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: